Search

everythinglearnresearchcommunity

for

Search:↓

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Adding a second method to PROTACs could improve cancer treatment.

Apremilast shows promise for several skin conditions but needs more research.

Adalimumab may cause severe hair loss in some patients.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Scalp condition healed with prednisone and tacrolimus.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

17β-estradiol can reduce inflammation in the skin.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Dupilumab for skin problems might reactivate hair loss in some patients.

Pentoxifylline effectively improves pretibial pruritic papular dermatitis.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

A man had a rare skin reaction from a hair loss medication, which improved after stopping the drug.

JAK inhibitors, PRP, and exosomes show promise for hair regrowth in Alopecia Areata.